Your browser is no longer supported. Please, upgrade your browser.
EXAS Exact Sciences Corporation monthly Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-0.77 Insider Own0.80% Shs Outstand148.15M Perf Week-1.32%
Market Cap12.50B Forward P/E- EPS next Y-1.02 Insider Trans-8.04% Shs Float147.87M Perf Month8.71%
Income-106.60M PEG- EPS next Q-0.67 Inst Own90.20% Short Float9.49% Perf Quarter3.80%
Sales1.06B P/S11.77 EPS this Y55.40% Inst Trans0.79% Short Ratio6.15 Perf Half Y2.66%
Book/sh17.13 P/B4.90 EPS next Y67.80% ROA-3.70% Target Price100.40 Perf Year-14.15%
Cash/sh8.26 P/C10.15 EPS next 5Y- ROE-6.70% 52W Range35.25 - 123.99 Perf YTD-9.29%
Dividend- P/FCF- EPS past 5Y12.50% ROI-1.90% 52W High-32.98% Beta1.87
Dividend %- Quick Ratio5.80 Sales past 5Y244.80% Gross Margin76.00% 52W Low135.72% ATR4.32
Employees4110 Current Ratio6.10 Sales Q/Q114.70% Oper. Margin-23.30% RSI (14)58.86 Volatility5.00% 5.03%
OptionableYes Debt/Eq0.61 EPS Q/Q-8.60% Profit Margin-10.00% Rel Volume0.27 Prev Close83.89
ShortableYes LT Debt/Eq0.60 EarningsMay 06 AMC Payout- Avg Volume2.28M Price83.10
Recom1.30 SMA201.22% SMA5016.42% SMA200-4.97% Volume397,440 Change-0.95%
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
May-29-20 08:00AM  Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020 PR Newswire
May-26-20 06:00AM  Exact Sciences to participate in June investor conferences PR Newswire
May-25-20 03:45PM  Edited Transcript of EXAS earnings conference call or presentation 6-May-20 9:00pm GMT Thomson Reuters StreetEvents
May-17-20 06:46AM  Could Exact Sciences Be a Millionaire-Maker Stock? Motley Fool
May-12-20 03:10PM  Pivoting From Poop: How Exact Sciences is Turning to Option #2 Yahoo Finance Video
10:23AM  Is Exact Sciences Stock a Buy? Motley Fool
May-11-20 10:19AM  Should Investors Buy the Dip in EXACT Sciences (EXAS) Stock? Insider Monkey
May-07-20 11:30AM  Exact Sciences Corp (EXAS) Q1 2020 Earnings Call Transcript Motley Fool +6.35%
10:09AM  Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands Zacks
May-06-20 08:05PM  Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates Zacks
03:00PM  EXACT Sciences Corp. to Host Earnings Call ACCESSWIRE
May-05-20 10:30AM  New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods PR Newswire
10:16AM  Should You Buy Exact Sciences (EXAS) Ahead of Earnings? Zacks
10:06AM  Varian (VAR) Earnings and Revenues Surpass Estimates in Q2 Zacks
08:45AM  Buy 5 Top Stocks Set to Beat Earnings Estimates Tomorrow Zacks
May-04-20 06:00AM  Exact Sciences to participate in May investor conference PR Newswire
May-03-20 07:36AM  2 Cheap Healthcare Stocks to Buy Now Motley Fool
Apr-30-20 10:49AM  Surmodics (SRDX) Q2 Earnings and Revenues Beat Estimates Zacks
Apr-29-20 12:34PM  Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-22-20 05:20AM  Exact Sciences Reports 63% Reduction For Cologuard Testing in April SmarterAnalyst
Apr-08-20 05:51PM  Why 'Kimtirement' is a real thing with this longtime biotech exec American City Business Journals +6.02%
06:00AM  Exact Sciences schedules first-quarter 2020 earnings call PR Newswire
Apr-02-20 09:00AM  10x Genomics Appoints Kim Popovits to Board of Directors GlobeNewswire
06:00AM  Exact Sciences Highlights The Opportunity To Seek Screening With Cologuard® Through Telehealth PR Newswire
Mar-26-20 05:45PM  Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know Zacks
01:50PM  Epic, Exact Sciences among Wisconsin tech firms responding to COVID-19 American City Business Journals
Mar-24-20 09:44AM  Exact Sciences Grows on New Deals, Down on Coronavirus Scare Zacks +16.11%
Mar-21-20 09:22AM  Is Exact Sciences Corporation's (NASDAQ:EXAS) CEO Pay Fair? Simply Wall St.
Mar-19-20 06:00AM  Exact Sciences Takes Action during COVID-19 Pandemic PR Newswire +32.48%
Mar-17-20 05:45PM  Exact Sciences (EXAS) Gains But Lags Market: What You Should Know Zacks
03:18PM  Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS) Insider Monkey
Mar-12-20 11:30AM  Exact Sciences (EXAS) Down 39.7% Since Last Earnings Report: Can It Rebound? Zacks -10.91%
Mar-04-20 07:37AM  The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies Benzinga
Feb-27-20 08:42AM  Genetic Test Gets Okayed by FDA: 4 Stocks to Keep an Eye On Zacks
Feb-25-20 08:28AM  The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement Benzinga -9.44%
Feb-24-20 10:39PM  Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2028 PR Newswire
04:01PM  Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 PR Newswire
Feb-19-20 05:44AM  Bull of the Day: Guardant Health (GH) Zacks
Feb-17-20 05:24AM  Edited Transcript of EXAS earnings conference call or presentation 11-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-12-20 03:52PM  Exact Sciences to acquire more biotech companies; plans to launch liver cancer test in 2020 American City Business Journals
09:18AM  The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga
08:56AM  Exact Sciences (EXAS) Q4 Earnings and Revenues Rise Y/Y Zacks
Feb-11-20 06:15PM  Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates Zacks
05:07PM  Exact Sciences beats income, revenue projections in 4Q earnings report American City Business Journals
04:05PM  Exact Sciences Announces Fourth-Quarter 2019 Results PR Newswire
07:23AM  The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
Feb-04-20 06:41PM  Should Growth Investors Buy this Cancer Screening Biotech Stock? Zacks
12:30PM  Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
11:44AM  What's in the Cards for Exact Sciences' (EXAS) Q4 Earnings? Zacks
Feb-03-20 05:45PM  Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know Zacks
04:05PM  Eaton Vance Worldwide Health Sciences Fund Buys 3 Stocks in 4th Quarter GuruFocus.com
01:01PM  Exact Sciences doubled capital investment, job creation goal in Wisconsin, per report American City Business Journals
Jan-27-20 05:50PM  Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know Zacks
06:00AM  Exact Sciences schedules fourth-quarter, full-year 2019 earnings call PR Newswire
Jan-24-20 11:24AM  Exact Sciences, GameStop, Intel, Intuitive Surgical and Skyworks highlighted as Zacks Bull and Bear of the Day Zacks
09:55AM  What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings? Zacks
09:06AM  Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings? Zacks
05:20AM  Bull of the Day: Exact Sciences (EXAS) Zacks
Jan-23-20 01:30PM  Exact Sciences' stock jumps after analysts question competitor's product American City Business Journals
10:45AM  Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings? Zacks
09:17AM  Will Segmental Growth Aid Hologic (HOLX) in Q1 Earnings? Zacks
08:23AM  What's in Store for Align Technology's (ALGN) Q4 Earnings? Zacks
Jan-22-20 07:30AM  Exact Sciences Gains After Rival's Colorectal Cancer Screening Product Falls Short TheStreet.com +10.55%
Jan-21-20 06:31AM  Is Exact Sciences Corporation (NASDAQ:EXAS) Trading At A 40% Discount? Simply Wall St.
Jan-20-20 09:13AM  Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines? Zacks
Jan-17-20 09:15AM  Another Milestone After Another Trade Deal Zacks
07:10AM  Exact Sciences (EXAS) Provides Q4 Expectations, Stock Falls Zacks
Jan-16-20 02:53PM  6 Guru Stocks With Negative Performances GuruFocus.com
09:52AM  Novavax Rises on Fast Track Designation to Influenza Vaccine Zacks
Jan-15-20 09:36AM  Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results Zacks
Jan-14-20 01:44PM  Exact Sciences (EXAS) Stock Has 40% Upside From Here, Says Analyst TipRanks
04:41AM  Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings? Zacks
Jan-13-20 01:51PM  Exact Sciences anticipates 2019 revenue over $876M, more than 1.6M completed Cologuard tests American City Business Journals -13.67%
11:30AM  Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year? Zacks
10:17AM  All 4 of Analysts' Favorite Stocks Fell Last Year GuruFocus.com
10:16AM  Can New Strategic Efforts Aid Apharia's (APHA) Q2 Earnings? Zacks
09:13AM  Top Ranked Momentum Stocks to Buy for January 13th Zacks
08:14AM  Can Cannabis Therapy Drive Aphria's (APHA) Q2 Earnings? Zacks
Jan-12-20 07:00PM  Exact Sciences Announces Preliminary Fourth Quarter 2019 Results PR Newswire
Jan-07-20 10:08AM  Exact Sciences Rides on Cologuard, Eyes Merger Synergies Zacks
Jan-06-20 09:55AM  Walgreens Boots (WBA) to Post Q1 Earnings: What's in Store? Zacks
Jan-02-20 06:00AM  Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire
Dec-31-19 12:00AM  Bitcoins 9,000,000% Rise This Decade Leaves the Skeptics Aghast Bloomberg
Dec-26-19 12:05PM  EXACT Sciences Corporation (EXAS) vs. Top 20 Hedge Fund Stocks in 2019 Insider Monkey
Dec-25-19 07:17AM  3 Biotech Stocks to Buy as the Sector Heats Up TipRanks
Dec-24-19 11:30AM  Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year? Zacks
Dec-17-19 11:33AM  Exact Sciences, Maker of the Cancer Test Cologuard, Is Vastly Undervalued, Analyst Says Barrons.com
Dec-16-19 06:53AM  Exact Sciences Corporation's (NASDAQ:EXAS) Path To Profitability Simply Wall St.
Dec-12-19 01:41PM  Theres more upside for biotech even after 24% gains in two months MarketWatch
06:00AM  New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-negative or Node-positive Early-stage Breast Cancer PR Newswire
Dec-04-19 08:35PM  Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS) Insider Monkey
04:30PM  Dr. David Ahlquist, co-inventor of Cologuard, named a Fellow of the National Academy of Inventors PR Newswire
Nov-18-19 10:17AM  Medtronic (MDT) to Report Q2 Earnings: What's in Store? Zacks
Nov-15-19 10:28AM  Why Cancer-Testing Specialist Exact Sciences Stock Is Up Today Barrons.com
Nov-10-19 06:55AM  If You Had Bought Exact Sciences (NASDAQ:EXAS) Shares Three Years Ago You'd Have Made 373% Simply Wall St.
Nov-08-19 12:22PM  Exact Sciences completes $2.8B acquisition of Genomic Health American City Business Journals
08:24AM  Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company PR Newswire
08:02AM  Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company PR Newswire
08:00AM  Exact Sciences Presents Data On Blood-Based Test For Detection Of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation PR Newswire
Nov-07-19 01:55PM  Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences PR Newswire
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stenhouse MarkPresident, CologuardApr 03Sale56.6911,948677,33229,571Apr 06 04:41 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000041,519Apr 06 04:41 PM
Doyle James EdwardDirectorFeb 28Sale77.542,000155,08032,440Mar 03 07:20 PM
Conroy Kevin TPresident and CEOFeb 28Sale80.179,750781,658992,963Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale80.172,383191,04558,578Mar 02 07:15 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.005,025061,141Mar 02 07:15 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0020,57501,002,713Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Sale80.271,627130,59956,116Feb 28 04:37 PM
Stenhouse MarkPresident, CologuardFeb 27Sale80.271,05184,36416,519Feb 28 04:39 PM
Conroy Kevin TPresident and CEOFeb 27Sale80.2713,8751,113,746982,138Feb 28 04:36 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0029,3370996,013Feb 28 04:36 PM
Stenhouse MarkPresident, CologuardFeb 26Option Exercise0.003,262017,570Feb 28 04:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,436057,743Feb 28 04:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale85.114,910417,89054,307Feb 26 05:13 PM
Conroy Kevin TPresident and CEOFeb 25Sale85.1118,1151,541,768966,676Feb 26 05:11 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0034,3250984,791Feb 26 05:11 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Option Exercise0.009,300059,217Feb 26 05:13 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Option Exercise35.7717,356620,77637,550Feb 21 04:58 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Sale100.0027,3562,735,60010,194Feb 21 04:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale100.681,153116,0842,495Feb 20 05:55 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64803,648Feb 20 05:55 PM
Hoof TorstenGeneral Manager, InternationalFeb 15Option Exercise0.002,09105,914Mar 27 04:15 PM
Cole G BradleyGeneral Manager - DiagnosticsJan 16Sale90.3010,000903,0008,653Jan 17 04:50 PM
Conroy Kevin TPresident and CEODec 16Option Exercise17.4811,440199,992950,466Dec 18 05:19 PM
Cole G BradleyGeneral Manager - DiagnosticsNov 21Sale80.3828,0162,251,92630,987Nov 25 05:18 PM
Johnson Scott C.SVP - Research and DevelopmentSep 12Sale108.633,527383,13812,311Sep 13 04:52 PM
Johnson Scott C.SVP - Research and DevelopmentSep 11Option Exercise0.007,500015,838Sep 13 04:52 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise5.3142,607226,42155,065Aug 02 04:24 PM
WYZGA MICHAEL SDirectorJul 31Option Exercise26.982,50067,45013,913Aug 02 04:25 PM
LEVANGIE DANIEL JDirectorJul 31Sale117.6442,6075,012,39812,458Aug 02 04:24 PM
Zanotti Katherine SDirectorJul 31Sale117.931,744205,67077,513Aug 02 04:28 PM
WYZGA MICHAEL SDirectorJul 31Sale117.935,000589,6508,913Aug 02 04:25 PM
Doyle James EdwardDirectorJul 31Sale117.932,808331,14734,440Aug 02 04:22 PM
Carey Thomas D.DirectorJul 31Sale117.6510,0001,176,48734,181Aug 02 04:20 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 30Sale105.609,8451,039,63249,917Jul 31 05:57 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Option Exercise0.0018,750059,762Jul 31 05:57 PM